|
US5837696A
(en)
*
|
1997-01-15 |
1998-11-17 |
The Research Foundation Of State University Of New York |
Method of inhibiting cancer growth
|
|
US6429204B1
(en)
|
1997-01-15 |
2002-08-06 |
University Of Miami |
Method of inhibiting cancer growth
|
|
AU2001599A
(en)
*
|
1997-12-19 |
1999-07-05 |
New York University |
Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
|
|
US6277061B1
(en)
|
1998-03-31 |
2001-08-21 |
The Research Foundation Of State University Of New York |
Method of inhibiting membrane-type matrix metalloproteinase
|
|
US6015804A
(en)
*
|
1998-09-11 |
2000-01-18 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds to enhance interleukin-10 production
|
|
US5977091A
(en)
*
|
1998-09-21 |
1999-11-02 |
The Research Foundation Of State University Of New York |
Method of preventing acute lung injury
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
BR9916536A
(pt)
*
|
1998-12-23 |
2002-01-02 |
Searle & Co |
Método para o tratamento ou prevenção de um distúrbio de neoplasia em um mamìfero em necessidade deste tratamento ou prevenção, e, combinação
|
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6984619B1
(en)
*
|
1999-03-19 |
2006-01-10 |
Arch Development Corporation |
Method for protection against tumor metastasis formation
|
|
DE10032256C2
(de)
*
|
2000-07-03 |
2003-06-05 |
Infineon Technologies Ag |
Chip-ID-Register-Anordnung
|
|
EP2311440A1
(en)
*
|
2001-04-05 |
2011-04-20 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
EP2327409A1
(en)
|
2001-07-13 |
2011-06-01 |
Paratek Pharmaceuticals, Inc. |
Tetracycline compound having target therapeutic activities
|
|
US20060194773A1
(en)
*
|
2001-07-13 |
2006-08-31 |
Paratek Pharmaceuticals, Inc. |
Tetracyline compounds having target therapeutic activities
|
|
RU2300380C2
(ru)
*
|
2001-10-05 |
2007-06-10 |
Тетрадженекс Фармасьютикалс, Инк. |
Производные тетрациклина и способы их применения
|
|
PE20030701A1
(es)
*
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
ES2551708T3
(es)
|
2002-01-08 |
2015-11-23 |
Paratek Pharmaceuticals, Inc. |
Compuestos de 4-desdimetilamino tetraciclina
|
|
EP2311451A1
(en)
|
2002-03-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
Amino-methyl substituted tetracycline compounds
|
|
EP1503981A4
(en)
|
2002-03-21 |
2007-08-15 |
Paratek Pharm Innc |
SUBSTITUTED TETRACYCLINE COMPOUNDS
|
|
JP2005526114A
(ja)
*
|
2002-05-06 |
2005-09-02 |
コッラジェネックス ファーマシューチカルス インコーポレイテッド |
粘膜炎及び真菌感染症の同時治療方法
|
|
JP2005533766A
(ja)
*
|
2002-05-20 |
2005-11-10 |
コッラジェネックス ファーマシューチカルス インコーポレイテッド |
アレルギー反応の治療方法
|
|
AU2003261161B2
(en)
|
2002-07-12 |
2009-09-10 |
Paratek Pharmaceuticals, Inc |
3, 10, and 12a substituted tetracycline compounds
|
|
CA2503446C
(en)
|
2002-10-24 |
2012-12-18 |
Paratek Pharmaceuticals, Inc. |
Methods of using substituted tetracycline compounds to modulate rna
|
|
WO2004091483A2
(en)
|
2003-04-07 |
2004-10-28 |
Shire Laboratories, Inc. |
Once daily formulations of tetracyclines
|
|
US20050143352A1
(en)
|
2003-07-09 |
2005-06-30 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
AU2004259661B2
(en)
|
2003-07-09 |
2011-11-10 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
|
JP5010284B2
(ja)
*
|
2004-01-15 |
2012-08-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
テトラサイクリン化合物の芳香族ａ環誘導体
|
|
EP2033950A1
(en)
|
2004-10-25 |
2009-03-11 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
EP1805134B1
(en)
|
2004-10-25 |
2012-06-20 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
|
US20070093455A1
(en)
*
|
2005-07-21 |
2007-04-26 |
Paul Abato |
10-substituted tetracyclines and methods of use thereof
|
|
WO2008079339A2
(en)
|
2006-12-21 |
2008-07-03 |
Paratek Pharmaceuticals, Inc. |
Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
|
|
CA2892739A1
(en)
|
2006-12-21 |
2008-07-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
|
EP2216323A3
(en)
*
|
2007-04-27 |
2010-12-29 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing and purifying aminoalkyl tetracycline compounds
|
|
EP2176216B1
(en)
*
|
2007-07-06 |
2012-04-25 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing 9-substituted minocycline
|
|
TWI680117B
(zh)
|
2008-05-19 |
2019-12-21 |
派洛泰克藥物股份有限公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
|
KR101746795B1
(ko)
|
2008-08-08 |
2017-06-13 |
테트라페이즈 파마슈티컬스, 인코포레이티드 |
Ｃ７-플루오로 치환된 테트라시클린 화합물
|
|
WO2010129057A2
(en)
|
2009-05-08 |
2010-11-11 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
NO2470500T3
(https=)
|
2009-08-28 |
2018-03-03 |
|
|
|
WO2011109899A1
(en)
*
|
2010-03-10 |
2011-09-15 |
University Health Network |
Use of tigecycline for treatment of cancer
|
|
DK2552890T3
(en)
|
2010-03-31 |
2017-04-03 |
Tetraphase Pharmaceuticals Inc |
POLYCYCLIC TETRACYCLINE COMPOUNDS
|
|
CA2883238C
(en)
|
2012-08-31 |
2021-11-23 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
CN105142631A
(zh)
*
|
2013-01-14 |
2015-12-09 |
健康诊所有限公司 |
抗癌药物和用途
|
|
HUE066360T2
(hu)
|
2016-10-19 |
2024-07-28 |
Tetraphase Pharmaceuticals Inc |
Eravaciklin kristályformái
|
|
US11197872B2
(en)
|
2017-04-21 |
2021-12-14 |
Lunella Biotech, Inc. |
Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
|
|
CA3060509A1
(en)
|
2017-04-21 |
2018-10-25 |
Federica Sotgia |
Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
|
|
US12006553B2
(en)
|
2017-05-19 |
2024-06-11 |
Lunella Biotech, Inc. |
Companion diagnostics for mitochondrial inhibitors
|
|
KR20200010343A
(ko)
|
2017-05-19 |
2020-01-30 |
루넬라 바이오테크 인코포레이티드 |
안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제
|
|
US12570604B2
(en)
|
2018-11-09 |
2026-03-10 |
Tetraphase Pharmaceuticals, Inc. |
Polymorphic forms of a tetracycline compound and uses thereof
|
|
CN115006411A
(zh)
*
|
2022-07-26 |
2022-09-06 |
中南大学湘雅医院 |
依拉环素类化合物的应用、药物及其制备方法
|